Lobe Sciences Executives Boost Ownership Past 40% to Preserve Capital

Vancouver, Tuesday, 9 June 2026.
Lobe Sciences leadership recently traded C$1.37 million in unpaid fees for shares, pushing their ownership above 40%. This strategic move preserves vital capital for advancing ongoing medical research.